1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4-5):309-16. https://doi.org/10.1016/j.oraloncology.2008.06.002 https://pubmed.ncbi.nlm.nih.gov/18804401 
2. Montero PH, Patel SG. Cancer of the oral cavity. Surg Oncol Clin N Am. 2015;24(3):491-508. https://doi.org/10.1016/j.soc.2015.03.006 https://pubmed.ncbi.nlm.nih.gov/25979396 
3. Radoï L, Luce D. A review of risk factors for oral cavity cancer: the importance of a standardized case definition. Community Dent Oral Epidemiol. 2013;41(2):97-109. https://doi.org/10.1111/j.1600-0528.2012.00710.x https://pubmed.ncbi.nlm.nih.gov/22882534 
4. Benzian M, Williams D. The Oral Health Atlas. 2nd ed. Geneva: FDI World Dental Federation; 2015. :6-69. 
5. International Agency for Research on Cancer. WHO: International Agency for Research on Cancer. A digital manual for the early diagnosis of oral neoplasia. Squamous cell carcinoma. [cited 2019 Mar 22]. 
6. Yete S, D’Souza W, Saranath D. High-risk human papillomavirus in oral cancer: clinical implications. Oncology. 2018;94(3):133-41. https://doi.org/10.1159/000485322 https://pubmed.ncbi.nlm.nih.gov/29241220 
7. Tay SK, Oon LL. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study. Int J STD AIDS. 2014;25(14):1013-21. https://doi.org/10.1177/0956462414528315 https://pubmed.ncbi.nlm.nih.gov/24648316 
8. Shah A, Malik A, Garg A, Mair M, Nair S, Chaturvedi P. Oral sex and human papilloma virus-related head and neck squamous cell cancer: a review of the literature. Postgrad Med J. 2017;93(1105):704-9. https://doi.org/10.1136/postgradmedj-2016-134603 https://pubmed.ncbi.nlm.nih.gov/28778951 
9. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3235-42. https://doi.org/10.1200/JCO.2015.61.6995 https://pubmed.ncbi.nlm.nih.gov/26351338 
10. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008;26(4):612-9. https://doi.org/10.1200/JCO.2007.14.1713 https://pubmed.ncbi.nlm.nih.gov/18235120 
11. Strojan P, Zadnik V, Šifrer R, Lanišnik B, Didanović V, Jereb S, et al. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection. Eur Arch Otorhinolaryngol. 2015;272(12):3805-14. https://doi.org/10.1007/s00405-014-3459-7 https://pubmed.ncbi.nlm.nih.gov/25542247 
12. Deschler DG, Richmon JD, Khariwala SS, Ferris RL, Wang MB. The “new” head and neck cancer patient-young, nonsmoker, nondrinker, and HPV positive: evaluation. Otolaryngol Head Neck Surg. 2014;151(3):375-80. https://doi.org/10.1177/0194599814538605 https://pubmed.ncbi.nlm.nih.gov/24925311 
13. Patel R. The state of oral health in Europe. [cited 2019 March 22]. 
14. Ustna votlina. In: Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B, eds. Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji. Ljubljana: Onkološki inštitut Ljubljana; 2009. :36-43. 
15. Ustno žrelo. In: Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B, eds. Preživetje bolnikov z rakom, zbolelih v letih 1991–2005 v Sloveniji. Ljubljana: Onkološki inštitut Ljubljana; 2009. :28-35. 
16. Lafaurie GI, Perdomo SJ, Buenahora MR, Amaya S, Díaz-Báez D. Human papilloma virus: an etiological and prognostic factor for oral cancer?. J Investig Clin Dent. 2018;9(2):e12313https://doi.org/10.1111/jicd.12313 https://pubmed.ncbi.nlm.nih.gov/29322686 
17. O’Rorke MA, Ellison MV, Murray LJ, Moran M, James J, Anderson LA. Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol. 2012;48(12):1191-201. https://doi.org/10.1016/j.oraloncology.2012.06.019 https://pubmed.ncbi.nlm.nih.gov/22841677 
18. slora.si. Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32). [cited [cited 2018 Mar 16]]. 
19. Brierley J, Gospodarowicz MK, Witterkind Ch, eds. TNM Classification of Malignant Tumors. Eighth edition. Oxford, UK, Hoboken, NY: John Wiley & Sons; 2017. 
20. Corp IB. IBM SPSS Statistics for Windows, Version 24.0. Armonk, NY: IBM Corp.; 2016. 
21. Joinpoint Regression Program. Statistical Methodology and Applications Branch, Surveillance Research Program. Bethesda, MD: National Cancer Institute; 2014. 
22. Moore S, Johnson N, Pierce A, Wilson D. The epidemiology of lip cancer: a review of global incidence and aetiology. Oral Dis. 1999;5(3):185-95. https://doi.org/10.1111/j.1601-0825.1999.tb00300.x https://pubmed.ncbi.nlm.nih.gov/10483063 
23.	Bota JP, Lyons AB, Carroll BT. Squamous cell carcinoma of the lip–a review of squamous cell carcinogenesis of the mucosal and cutaneous junction. Dermatol Surg. 2017;43(4):494-506. https://doi.org/10.1097/DSS.0000000000001020 https://pubmed.ncbi.nlm.nih.gov/28157733 
24. World Health Organization, International Agency for Research on Cancer. Human papillomaviruses. Lyon: IARC; 2007. :223-76. 
25. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-20. https://doi.org/10.1093/jnci/92.9.709 https://pubmed.ncbi.nlm.nih.gov/10793107 
26. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011;29(32):4294-301. https://doi.org/10.1200/JCO.2011.36.4596 https://pubmed.ncbi.nlm.nih.gov/21969503 
27. Diz P, Meleti M, Diniz-Freitas M, Vescovi P, Warnakulasuriya S, Johnson NW, et al. Oral and pharyngeal cancer in Europe. Transl Res Oral Oncol. 2017;2:1-13. 
28. WHO | Metrics: Population Attributable Fraction (PAF). 
29. Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4(9):e609-16. https://doi.org/10.1016/S2214-109X(16)30143-7 https://pubmed.ncbi.nlm.nih.gov/27470177 
30.	de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70. https://doi.org/10.1002/ijc.30716 https://pubmed.ncbi.nlm.nih.gov/28369882 
31. Haeggblom L, Ramqvist T, Tommasino M, Dalianis T, Näsman A. Time to change perspectives on HPV in oropharyngeal cancer. A systematic review of HPV prevalence per oropharyngeal sub-site the last 3 years. Papillomavirus Res. 2017;4:1-11. https://doi.org/10.1016/j.pvr.2017.05.002 https://pubmed.ncbi.nlm.nih.gov/29179862 
32. Public Health England. National Cancer Registration and Analysis Service, NCRAS. The importance of skin cancer registration – NCIN data briefing. 
33. Rak v Sloveniji 2017. Ljubljana: Onkološki inštitut Ljubljana, Epidemiologija in register raka, Register Raka Republike Slovenije; 2017. :9-11. 
34. Anselmo Lima C, Sampaio Lima M, Maria Da Silva A, Prado Nunes MA, Macedo Lima MM, Oliveira Santos M, et al. Do cancer registries play a role in determining the incidence of non-melanoma skin cancers?. Eur J Dermatol. 2018;28(2):169-76. https://doi.org/10.1684/ejd.2018.3248 https://pubmed.ncbi.nlm.nih.gov/29619990 
35. Slovenija : Slovenija in rak; Osnovni epidemiološki podatki o raku. Glava in vrat (C00–C14, C30–C32). [cited 2018 Mar 16]. 
36. Nacionalni inštitut za varno zdravje. Slovenija. Varno s soncem v vrtcih. [cited 2019 Mar 22]. 
37. Nacionalni inštitut za varno zdravje. Slovenija. Varno s soncem v osnovnih šolah. [cited 2019 Mar 22]. 
38. Zakon o omejevanju uporabe tobačnih izdelkov. Ur l RS. 1996(57); 2002(119); 2005(101); 2007(60). 
39. Zakon o omejevanju porabe alkohola – ZOPA. Ur l RS. 2003(15). 
40. Toš N, Klinar P, Markič B, Roter Z, Vreg F, Trampuž C. Slovenian Public Opinion survey 1978. Ljubljana: Faculty of Social Sciences University of Ljubljana and Public Opinion and Mass Communication Research Centre; 1978. 
41.	Koprivnikar H. Tobak. In: Zakotnik J, Tomšič S, Kofol Bric T, Korošec I, Zaletel-Kragelj L, eds. Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije; 2012. :71-88. 
42. Lovrečič M, Lovrečič B, Tomšič S. Alkohol. Zakotnik J, Tomšič S, Kofol Bric T, Korošec I, Zaletel-Kragelj L, eds. Zdravje in vedenjski slog prebivalcev Slovenije – trendi v raziskavah CINDI 2001–2004–2008. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije; 2012. :89-107. 
43. Lovrečič M, Lovrečič B. Pitje alkohola. In: Vinko M, Kofol Bric T, Korošec A, Tomšič S, Vrdelja M, eds. Kako skrbimo za zdravje? Z zdravjem povezan vedenjski slog prebivalcev Slovenije 2016. Ljubljana: Inštitut za varovanje zdravja Republike Slovenije; 2018. :17-20. 
44. WHO | Global information system on alcohol and health. 
45. Bravi F, Edefonti V, Randi G, Ferraroni M, La Vecchia C, Decarli A. Dietary patterns and upper aerodigestive tract cancers: an overview and review. Ann Oncol. 2012;23(12):3024-39. https://doi.org/10.1093/annonc/mds197 https://pubmed.ncbi.nlm.nih.gov/22967993 
46. Olaleye O, Ekrikpo U, Lyne O, Wiseberg J. Incidence and survival trends of lip, intra-oral cavity and tongue base cancers in south-east England. Ann R Coll Surg Engl. 2015;97(3):229-34. https://doi.org/10.1308/003588414X14055925061676 https://pubmed.ncbi.nlm.nih.gov/26263810 
47.	van Dijk BA, Brands MT, Geurts SM, Merkx MA, Roodenburg JL. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer. 2016;139(3):574-83. https://doi.org/10.1002/ijc.30107 https://pubmed.ncbi.nlm.nih.gov/27038013 
48. Johansen J, Grau Eriksen J, Academy of Geriatric Cancer Research (AgeCare). Trends in cancer of the head and neck in the elderly in Denmark, 1980-2012. Acta Oncol. 2016;55(sup1):13-8. https://doi.org/10.3109/0284186X.2015.1114672 https://pubmed.ncbi.nlm.nih.gov/26760291 
49. Kingsley K, O’Malley S, Ditmyer M, Chino M. Analysis of oral cancer epidemiology in the US reveals state-specific trends: Implications for oral cancer prevention. BMC Public Health. 2018;8:87https://doi.org/10.1186/1471-2458-8-87 https://pubmed.ncbi.nlm.nih.gov/18331638 
50. Elwood JM, Youlden DR, Chelimo C, Ioannides SJ, Baade PD. Comparison of oropharyngeal and oral cavity squamous cell cancer incidence and trends in New Zealand and Queensland, Australia. Cancer Epidemiol. 2014;38(1):16-21. https://doi.org/10.1016/j.canep.2013.12.004 https://pubmed.ncbi.nlm.nih.gov/24445141 
51. Onkološki inštitut=Institut of Oncology Ljubljana. Register raka Republike Slovenije in drugi registri. [cited 2018 Jun 3]. 
52. Tapia JL, Goldberg LJ. The challenges of defining oral cancer: analysis of an ontological approach. Head Neck Pathol. 2011;5(4):376-84. https://doi.org/10.1007/s12105-011-0300-0 https://pubmed.ncbi.nlm.nih.gov/21915705 
53. Head and neck cancers. What are cancers of the head and neck?. 
54. Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al.; eds. AJCC Cancer Staging Manual. 8th ed. Chicago: Springer; 2017. 
55. Lui JC, Pagedar NA, Goldenberg D, Gross ND, eds. Oral cavity cancer. Los Angeles, CA: American Head and Neck Society; 2017. 
56. Oral cavity and oropharyngeal cancer. What are oral cavity and oropharyngeal cancers?. 
57. Mouth and oropharyngeal cancer. About mouth and oropharyngeal cancer. 
58. Gašperšič D, Košir N, Jevnikar N. Razvoj obraza in ustne votline. In: Gašperšič C, ed. Razvoj obraza, ustne votline in zobnega organa. 2nd ed. Ljubljana: Medicinska fakulteta; 2002. :7:25
59. Trotta BM, Pease CS, Rasamny JJ, Raghavan P, Mukherjee S. Oral cavity and oropharyngeal squamous cell cancer: key imaging findings for staging and treatment planning. Radiographics. 2011;31(2):339-54. https://doi.org/10.1148/rg.312105107 https://pubmed.ncbi.nlm.nih.gov/21415183 
60. What Are the Risk Factors and Potential Causes for Salivary Gland Cancer?. 2018[cited [cited 2018 Jun 3]]. 
61.	Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VM, Zhang G, et al. Etiological factors of nasopharyngeal carcinoma. Oral Oncol. 2014;50(5):330-8. https://doi.org/10.1016/j.oraloncology.2014.02.006 https://pubmed.ncbi.nlm.nih.gov/24630258 
62. Zeng MS, Zeng YX. Pathogenesis and etiology of nasopharyngeal carcinoma. In: Lu JJ, Cooper JS, Lee AW, eds. Nasopharyngeal Cancer: Multidisciplinary Management. Berlin: Springer Science & Business Media; 2010. :9-25. https://doi.org/10.1007/978-3-540-92810-2_2 
63. Zora. Državni program zgodnjega odkrivanja predrakavih sprememb materničnega vratu. 2018[cited [cited 2019 Mar 7]]. 
64. Muñoz N, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325-39. https://doi.org/10.1093/jnci/djp534 https://pubmed.ncbi.nlm.nih.gov/20139221 
65. Giuliano AR, Palefsky JM, Goldstone S, Moreira ED, Penny ME, Aranda C, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med. 2011;364(5):401-11. https://doi.org/10.1056/NEJMoa0909537 https://pubmed.ncbi.nlm.nih.gov/21288094 
66.	Guo T, Eisele DW, Fakhry C. The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer. 2016;122(15):2313-23. https://doi.org/10.1002/cncr.29992 https://pubmed.ncbi.nlm.nih.gov/27152637 
67. Arbyn M, de Sanjosé S, Saraiya M, Sideri M, Palefsky J, Lacey C, et al. EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer. 2012;131(9):1969-82. https://doi.org/10.1002/ijc.27650 https://pubmed.ncbi.nlm.nih.gov/22623137 
68.	Cobos C, Figueroa JA, Mirandola L, Colombo M, Summers G, Figueroa A, et al. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review. Int Rev Immunol. 2014;33(5):383-401. https://doi.org/10.3109/08830185.2014.911857 https://pubmed.ncbi.nlm.nih.gov/24811210 
69. Terlević Dabić D. Vloga zobozdravnika – preventiva in zgodnje odkrivanje raka ustne votline. In: Kansky A, Terlević Dabić D, eds. Zobozdravnik vidi bolje. Zato lahko reši življenje : Zbornik predavanj. 2017 Mar 18; Ljubljana, Slovenia. Ljubljana: Zdravniška zbornica Slovenije; 2017. 
70. Kocjančič A. Telesna preiskava. In: Kocijančič A, ed. Klinična preiskava. Ljubljana: Littera picta; 2017. :10
71. Smernice za zdravljenje tumorjev glave in vratu. 2018[cited [cited 2018 Jun 3]]. 
72. WHO | Evropski kodeks proti raku. 2019[cited 2019 Mar 8]. 
